A randomised trial of two cisplatin-containing chemotherapy regimens in patients with Stage III-B and IV non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A randomised trial of two cisplatin-containing chemotherapy regimens in patients with Stage III-B and IV non-small cell lung cancer

Published:1995-06 Issue:3 Volume:12 Page:237-246
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Erkisi Melek,Doran Figen,Burgut Refik,Kocabas Ali

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference17 articles.

1. Etoposide in the management of non-small cell lung cancer;Ruckdeschel;Cancer,1991

2. Ifosfamide in non-small cell lung cancer: a review;Eberhardt;Sem Oncol,1992

3. Mitomycin, ifosfamide and cisplatin in non-small cell lung cancer;Cullen;Oncology,1993

4. Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer;Shepherd;Sem Oncol,1992

5. Phase II study of cisplatin, ifosfamide and etoposide combination for advanced non-small cell lung cancer. Final report;Shirinian;Sem Oncol,1992

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease;Cochrane Database of Systematic Reviews;2012-04-18

2. Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease;Cochrane Database of Systematic Reviews;2007-10-17

3. Benefits of Adding a Drug to a Single-Agent or a 2-Agent Chemotherapy Regimen in Advanced Non–Small-Cell Lung Cancer;JAMA;2004-07-28

4. A phase III randomised study comparing two differentdose-intensity regimens as induction chemotherapy followedby thoracic irradiation in patients with advanced locoregionalnon-small-cell lung cancer;Annals of Oncology;2004-03

5. Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer;European Journal of Cancer;2003-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3